| RS2476457200 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476465516 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS2476467657 |
EVC
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS2476467795 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS2476474498 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS2476478867 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476478959 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476479412 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476480847 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476480900 |
TET2
|
Health Risk |
Pathogenic |
EBV-positive nodal T- and NK-cell lymphoma, EBV-positive nodal T- and NK-cell lymphoma |
| RS2476483849 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476483877 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476484066 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476484912 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476486500 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476487058 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476487087 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476487562 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476490195 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476490203 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476490501 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476493668 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476493944 |
TET2
|
Health Risk |
Pathogenic |
EBV-positive nodal T- and NK-cell lymphoma, EBV-positive nodal T- and NK-cell lymphoma |
| RS2476494544 |
TET2
|
Health Risk |
Pathogenic |
EBV-positive nodal T- and NK-cell lymphoma, EBV-positive nodal T- and NK-cell lymphoma |
| RS2476495796 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |
| RS2476496611 |
ALPK1
|
Health Risk |
Pathogenic |
Retinal dystrophy, optic nerve edema |
| RS2476496988 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476498043 |
TET2
|
Health Risk |
Likely pathogenic |
Immunodeficiency 75, Immunodeficiency 75 |
| RS2476498267 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476498425 |
TET2
|
Health Risk |
Pathogenic |
EBV-positive nodal T- and NK-cell lymphoma, EBV-positive nodal T- and NK-cell lymphoma |
| RS2476499310 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2476499461 |
FRAS1
|
Health Risk |
Likely pathogenic |
— |
| RS2476499844 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476499894 |
TET2
|
Health Risk |
Likely pathogenic |
— |
| RS2476501020 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476501205 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476501487 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476501613 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476501669 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476502798 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476502834 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476503118 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476503281 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476503712 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476504310 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476505738 |
TET2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2476508282 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476509596 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |
| RS2476510505 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476513684 |
FRAS1
|
Health Risk |
Likely pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS2476513919 |
FRAS1
|
Health Risk |
Likely pathogenic |
— |
| RS2476517697 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476517777 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476518062 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476518574 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS2476518716 |
FRAS1
|
Health Risk |
Likely pathogenic |
— |
| RS2476523240 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476523755 |
BBS7
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome |
| RS2476523833 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |
| RS2476527079 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476529732 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |
| RS2476529741 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |
| RS2476533151 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476533266 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476533556 |
TET2
|
Health Risk |
Pathogenic |
Third degree atrioventricular block, Third degree atrioventricular block |
| RS2476533686 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476533813 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476533846 |
BBS7
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Retinal dystrophy |
| RS2476534000 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476537310 |
TET2
|
Health Risk |
Pathogenic |
Clonal hematopoiesis, Clonal hematopoiesis |
| RS2476537887 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476537984 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476537994 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS2476539565 |
NFKB1
|
Health Risk |
Likely pathogenic |
Common variable immunodeficiency, Immunodeficiency |
| RS2476539670 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476539997 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476540252 |
FRAS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS2476541780 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2476544267 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476544279 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476546480 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476547379 |
KCNH2
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2476547907 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |
| RS2476548653 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476548784 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476548951 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476562023 |
NFKB1
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS2476562375 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 7, Gastric cancer |
| RS2476562616 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476562737 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476563154 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |
| RS2476563282 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |
| RS2476567100 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476567319 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476575208 |
FRAS1
|
Health Risk |
Likely pathogenic |
— |
| RS2476575540 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2476579225 |
COL25A1
|
Health Risk |
Pathogenic |
Fibrosis of extraocular muscles, congenital |
| RS2476581538 |
NFKB1
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS2476583005 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2476584179 |
BBS7
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome |